Effectiveness and safety of vedolizumab in biologically naïve patients: A real-world multi-centre study

BACKGROUND: Biologically naïve patients with inflammatory bowel disease treated with vedolizumab (VDZ) are largely underrepresented in real-world cohorts. A multi-centre, observational cohort study was performed on the effectiveness and safety of VDZ in biologically naïve subjects with Crohn’s disea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:United European Gastroenterol J
Main Authors: Macaluso, Fabio Salvatore, Fries, Walter, Renna, Sara, Viola, Anna, Muscianisi, Marco, Cappello, Maria, Guida, Laura, Siringo, Sebastiano, Camilleri, Salvatore, Garufi, Serena, Privitera, Antonino Carlo, Belluardo, Nunzio, Giangreco, Emiliano, Bertolami, Carmelo, Vassallo, Roberto, Rizzuto, Giulia, Orlando, Rosalba, Ventimiglia, Marco, Orlando, Ambrogio
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7724546/
https://ncbi.nlm.nih.gov/pubmed/32772830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640620948802
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados